Valuation: ABL Diagnostics

Market Cap 4.05Cr 4.67Cr 3.8Cr 3.46Cr 6.51Cr 445.87Cr 6.62Cr 45Cr 17Cr 223.19Cr 18Cr 17Cr 744.54Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.14Cr 4.78Cr 3.88Cr 3.54Cr 6.66Cr 456.14Cr 6.77Cr 46Cr 18Cr 228.33Cr 18Cr 18Cr 761.69Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
6.2%
Yield 2024
2.03%
Yield 2025 3.67%
1 day-0.79%
1 week+0.81%
Current month+3.31%
3 months-26.04%
6 months-30.56%
Current year-16.67%
1 week 2.4
Extreme 2.4
2.62
1 month 2.18
Extreme 2.18
2.74
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
28/07/26
Advanced Biological Laboratories SA
SellCompany -60,000 0.3723%
20/07/26
Advanced Biological Laboratories SA
SellCompany -65,616 0.4072%
06/07/26
Advanced Biological Laboratories SA
SellCompany -62,308 0.3867%
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%+0.81%-44.44%-71.59% 4.67Cr
+0.32%+3.07%-14.01%+5.66% 19TCr
-0.20%+5.42%-2.51%+8.54% 12TCr
-1.32%-4.62%+6.52%+65.45% 5.92TCr
+0.32%+3.92%+38.42%+65.14% 5.57TCr
-0.88%+2.77%-7.14%-35.54% 4.96TCr
+0.75%+10.19%+14.41%-18.09% 3.45TCr
+0.23%+3.10% - - 3.12TCr
-1.74%-0.70%+40.59%-12.31% 2.44TCr
+1.98%+12.62%-2.80%+25.91% 2.43TCr
Average -0.13%+3.76%+3.23%+3.69% 5.87TCr
Weighted average by Cap. -0.05%+3.53%+1.08%+13.53%

Financials

2024 2025
Net sales 5.87 6.77 5.5 5.02 9.44 646.26 9.59 64.79 25.29 323.5 25.42 24.87 1.08T 7.97 9.19 7.47 6.81 12.81 877.06 13.02 87.92 34.33 439.04 34.5 33.75 1.46T
Net income 3L 3L 3L 2L 5L 3.14Cr 5L 31.48L 12.29L 1.57Cr 12.35L 12.08L 5.24Cr 10L 11.38L 9L 8L 15.87L 11Cr 16.12L 1.09Cr 42.52L 5.44Cr 42.74L 41.81L 18Cr
Net Debt 20.24L 23.35L 18.97L 17.3L 32.55L 22Cr 33.07L 2.23Cr 87.21L 11Cr 87.66L 85.76L 37Cr 9L 10.76L 9L 8L 15L 10Cr 15.24L 1.03Cr 40.19L 5.14Cr 40.39L 39.52L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
14/26/14 2.500 -0.79% 110
13/26/13 €2.520 +2.44% 2,269
12/26/12 €2.460 -1.60% 8,218
11/26/11 €2.500 +3.31% 2,920
10/26/10 €2.420 -2.42% 4,672

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock